Diphtheria toxin‐based anti‐human CD19 immunotoxin for targeting human CD19(+) tumors

CD19 is expressed on normal and neoplastic B cells and is a promising target for immunotherapy. However, there is still an unmet need to further develop novel therapeutic drugs for the treatment of the refractory/relapsing human CD19(+) tumors. We have developed a diphtheria toxin‐based anti‐human C...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Qian, Wang, Zhaohui, Zhang, Huiping, Huang, Qi, Madsen, Joren C., Sachs, David H., Huang, Christene A., Wang, Zhirui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527461/
https://www.ncbi.nlm.nih.gov/pubmed/28306193
http://dx.doi.org/10.1002/1878-0261.12056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527461/
https://www.ncbi.nlm.nih.gov/pubmed/28306193
http://dx.doi.org/10.1002/1878-0261.12056

Ejemplares similares